Kirpekar Sahil 4
4 · ATAI Life Sciences N.V. · Filed Mar 16, 2023
Insider Transaction Report
Form 4
Kirpekar Sahil
Chief Business Officer
Transactions
- Award
Stock Option
2023-03-14+275,000→ 275,000 totalExercise: $1.18Exp: 2033-03-14→ Common Shares (275,000 underlying) - Award
Restricted Stock Unit
2023-03-14+200,000→ 200,000 total→ Common Shares (200,000 underlying)
Footnotes (2)
- [F1]The stock option shall vest as to 25% of the underlying shares on March 14, 2024, and in 36 substantially equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.